Testing an inotrope medicine versus placebo in shock patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies whether an inotrope medicine (a drug that helps the heart pump) works better than a placebo in adults in intensive care with cardiogenic shock. It may help doctors find safer, more effective treatment for this life-threatening condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently in the intensive care unit
- Your doctors have told you you have cardiogenic shock in SCAI class C or D
- You (or your substitute decision-maker) can agree to the study consent
- You are not pregnant and not breast-feeding
- You have not had milrinone or dobutamine in the last 24 hours before randomization
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called invobenitug for people in cardiogenic shock, a condition where the heart can't pump enough blood. The drug may help improve blood flow and reduce the need for strong blood pressure medicines.
This early study looks at how well the heart is pumping in people with cardiogenic shock, using measurements taken during a right-heart catheter (a small pressure-monitoring test). It may help doctors better assess heart function and guide next-step treatments like LVAD, heart transplant, or valve surgery.
This study is testing a device called an intra-aortic balloon pump (a small balloon placed in your heart's main artery to help it pump) for people in the early stages of cardiogenic shock, a condition where the heart can't pump enough blood. The goal is to see if adding this supportive device early on improves outcomes for patients with heart attacks or other heart problems.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This trial is testing different approaches (medications and mechanical support) to help people with acute heart failure and cardiogenic shock (a sudden drop in the heart's pumping ability). It looks at how well these treatments work in a network of hospitals to improve outcomes.
Hear when a new Shock, Cardiogenic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.